IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Stonepine Capital Management, LLC

Q4 2015 Holdings

Filed 2016-02-11 | 13 holdings | $85.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vanda Pharmaceuticals Inc(VNDA)COM921659108$17.9K1,918,92920.9%
CTI Biopharma CorpCOM12648L106$13.2K10,698,61815.4%
Sciclone Pharmaceuticals IncCOM80862K104$10.8K1,175,57412.7%
Tobira Therapeutics IncCOM88883P101$8.4K833,3779.8%
Sagent Pharmaceuticals IncCOM786692103$7.4K462,8248.6%
Pernix Therapeutics HoldingsCOM71426V108$7.3K2,484,6498.6%
Pain Therapeutics IncCOM69562K100$6.3K3,575,0007.3%
Foundation Medicine IncCOM350465100$3.6K173,0494.3%
Vericel Corp(VCEL)COM92346J108$3.6K1,376,8874.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$2.3K71,1472.8%
Derma Sciences IncCOM249827502$2.3K507,7992.7%
Cutera Inc(CUTREUR)COM232109108$1.3K100,0001.5%
Recro Pharma IncCOM75629F109$1.1K116,9011.2%